MEDFORD, N.Y., May 11, 2011 /PRNewswire/ -- Chembio Diagnostics, Inc. (OTC.QB:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, and is the only New York-based manufacturer of rapid HIV/AIDS testing products, announced today it will be taking an active role in